Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David D'Cruz

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Rheumatology International|September 24, 2025
A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trialMelanie Sloan, Thomas A Pollak, David D'Cruz, et al.
Arthritis and Rheumatism|February 5, 2010
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosusSean G O'Neill, Ian Giles, Anastasia Lambrianides, et al.
Medicine|November 18, 2008
Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literatureManuel Ramos-Casals, María José Cuadrado, Paula Alba, et al.
Rheumatology (Oxford, England)|January 7, 2022
Will 'the feeling of abandonment' remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and cliniciansMelanie Sloan, Rupert Harwood, Caroline Gordon, et al.
Rheumatology (Oxford, England)|October 26, 2021
Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and cliniciansMelanie Sloan, Elliott Lever, Rupert Harwood, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Lupus|June 6, 2020
Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods studyLindsay M Bearne, Julie Bieles, Sofia Georgopoulou, et al.
Kidney International Reports|May 2, 2022
Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus NephritisElisabeth M J Bos, Shirish R Sangle, Suzanne Wilhelmus, et al.
Rheumatology (Oxford, England)|May 26, 2012
Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigenYuan Zhao, Edward Odell, Lee Meng Choong, et al.
JACC. Cardiovascular Imaging|July 24, 2014
Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patientsNiharika Varma, Rocio Hinojar, David D'Cruz, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Rheumatology International|September 24, 2025
A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trialMelanie Sloan, Thomas A Pollak, David D'Cruz, et al.
Arthritis and Rheumatism|February 5, 2010
Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosusSean G O'Neill, Ian Giles, Anastasia Lambrianides, et al.
Medicine|November 18, 2008
Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literatureManuel Ramos-Casals, María José Cuadrado, Paula Alba, et al.
Rheumatology (Oxford, England)|January 7, 2022
Will 'the feeling of abandonment' remain? Persisting impacts of the COVID-19 pandemic on rheumatology patients and cliniciansMelanie Sloan, Rupert Harwood, Caroline Gordon, et al.
Rheumatology (Oxford, England)|October 26, 2021
Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and cliniciansMelanie Sloan, Elliott Lever, Rupert Harwood, et al.
RMD Open|August 19, 2025
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension studyJoan T Merrill, Amit Saxena, Martin Aringer, et al.
Lupus|June 6, 2020
Fatigue in adults with primary antiphospholipid syndrome: findings from a mixed-methods studyLindsay M Bearne, Julie Bieles, Sofia Georgopoulou, et al.
Kidney International Reports|May 2, 2022
Use of Glomerular CD68+ Cells as a Surrogate Marker for Endocapillary Hypercellularity in Lupus NephritisElisabeth M J Bos, Shirish R Sangle, Suzanne Wilhelmus, et al.
Rheumatology (Oxford, England)|May 26, 2012
Granulomatosis with polyangiitis involves sustained mucosal inflammation that is rich in B-cell survival factors and autoantigenYuan Zhao, Edward Odell, Lee Meng Choong, et al.
JACC. Cardiovascular Imaging|July 24, 2014
Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patientsNiharika Varma, Rocio Hinojar, David D'Cruz, et al.
Pageof 12